A $2-million investment in psychedelic medicine at St. Joseph’s Healthcare Hamilton is accelerating psilocybin research in Canada. We break down what this means for therapeutic access, product quality, and the future of the magic mushroom community.
A $2-million investment in psychedelic medicine at St. Joseph’s Healthcare Hamilton is accelerating psilocybin research in Canada. We break down what this means for therapeutic access, product quality, and the future of the magic mushroom community.